Naykky M Singh Ospina1, Diliara Bagautdinova2, Ian Hargraves3, Diana Barb1, Sreevidya Subbarayan1, Ashok Srihari1, Shu Wang4, Spyridoula Maraka5,6, Carma L Bylund2, Debbie Treise2, Victor Montori7, Juan P Brito7. 1. Division of Endocrinology, Department of Medicine, University of Florida, Gainesville, Florida, USA. 2. Department of Public Relations, College of Journalism and Communications, University of Florida, Gainesville, Florida, USA. 3. Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA. 4. Department of Biostatistics, University of Florida Health Cancer Center, University of Florida, Gainesville, Florida, USA. 5. Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. 6. Medicine Service, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA. 7. Knowledge and Evaluation Research Unit in Endocrinology (KER_Endo), Mayo Clinic, Rochester, Minnesota, USA.
Abstract
OBJECTIVE: To support patient-centred care and the collaboration of patients and clinicians, we developed and pilot tested a conversation aid for patients with thyroid nodules. DESIGN, PATIENT AND MEASUREMENTS: We developed a web-based Thyroid NOdule Conversation aid (TNOC) following a human-centred design. A proof of concept observational pre-post study was conducted (TNOC vs. usual care [UC]) to assess the impact of TNOC on the quality of conversations. Data sources included recordings of clinical visits, post-encounter surveys and review of electronic health records. Summary statistics and group comparisons are reported. RESULTS: Sixty-five patients were analysed (32 in the UC and 33 in the TNOC cohort). Most patients were women (89%) with a median age of 57 years and were incidentally found to have a thyroid nodule (62%). Most thyroid nodules were at low risk for thyroid cancer (71%) and the median size was 1.4 cm. At baseline, the groups were similar except for higher numeracy in the TNOC cohort. The use of TNOC was associated with increased involvement of patients in the decision-making process, clinician satisfaction and discussion of relevant topics for decision making. In addition, decreased decisional conflict and fewer thyroid biopsies as the next management step were noted in the TNOC cohort. No differences in terms of knowledge transfer, length of consultation, thyroid cancer risk perception or concern for thyroid cancer diagnosis were found. CONCLUSION: In this pilot observational study, using TNOC in clinical practice was feasible and seemed to help the collaboration of patients and clinicians.
OBJECTIVE: To support patient-centred care and the collaboration of patients and clinicians, we developed and pilot tested a conversation aid for patients with thyroid nodules. DESIGN, PATIENT AND MEASUREMENTS: We developed a web-based Thyroid NOdule Conversation aid (TNOC) following a human-centred design. A proof of concept observational pre-post study was conducted (TNOC vs. usual care [UC]) to assess the impact of TNOC on the quality of conversations. Data sources included recordings of clinical visits, post-encounter surveys and review of electronic health records. Summary statistics and group comparisons are reported. RESULTS: Sixty-five patients were analysed (32 in the UC and 33 in the TNOC cohort). Most patients were women (89%) with a median age of 57 years and were incidentally found to have a thyroid nodule (62%). Most thyroid nodules were at low risk for thyroid cancer (71%) and the median size was 1.4 cm. At baseline, the groups were similar except for higher numeracy in the TNOC cohort. The use of TNOC was associated with increased involvement of patients in the decision-making process, clinician satisfaction and discussion of relevant topics for decision making. In addition, decreased decisional conflict and fewer thyroid biopsies as the next management step were noted in the TNOC cohort. No differences in terms of knowledge transfer, length of consultation, thyroid cancer risk perception or concern for thyroid cancer diagnosis were found. CONCLUSION: In this pilot observational study, using TNOC in clinical practice was feasible and seemed to help the collaboration of patients and clinicians.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Erik P Hess; Meghan A Knoedler; Nilay D Shah; Jeffrey A Kline; Maggie Breslin; Megan E Branda; Laurie J Pencille; Brent R Asplin; David M Nestler; Annie T Sadosty; Ian G Stiell; Henry H Ting; Victor M Montori Journal: Circ Cardiovasc Qual Outcomes Date: 2012-04-10
Authors: Claudia L Zeballos-Palacios; Ian G Hargraves; Peter A Noseworthy; Megan E Branda; Marleen Kunneman; Bruce Burnett; Michael R Gionfriddo; Christopher J McLeod; Haeshik Gorr; Juan Pablo Brito; Victor M Montori Journal: Mayo Clin Proc Date: 2019-01-11 Impact factor: 7.616
Authors: Naykky Singh Ospina; Ana Castaneda-Guarderas; Russell Ward; Juan P Brito; Spyridoula Maraka; Claudia Zeballos Palacios; Kathleen J Yost; Diana S Dean; Victor M Montori Journal: Endocrine Date: 2018-06-16 Impact factor: 3.633
Authors: Naykky Singh Ospina; Spyridoula Maraka; Ana E Espinosa De Ycaza; Hyeong Sik Ahn; M Regina Castro; John C Morris; Victor M Montori; Juan P Brito Journal: Endocrine Date: 2016-08-10 Impact factor: 3.633